BPC-157 Ultra Probiotic - 60 capsules

INVESTIGATIONAL STATUS NOTICE (PLACE AT TOP OF PDP, ABOVE THE FOLD)

Important: BPC-157 is an investigational synthetic peptide compound. It has not been approved by the Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease. All research cited on this page is from preclinical animal studies. These findings are preliminary and may not translate to effects in humans. This product is intended for adults who wish to explore BPC-157 as part of a general wellness regimen and who understand its investigational nature.

BPC-157: Cutting-Edge Research Peptide plus Powerful Probiotics*

Based on preliminary preclinical and clinical research, BPC-157 Ultra Probiotic:

• Promotes a balanced, thriving microbiome*^1-3
• Supports gut lining comfort and normal barrier function*^2,4
• Delivers butyrate and supports its natural production*^2,3
• Encourages a healthy inflammatory response within the GI tract*^1,5,6
• Supports gut-brain signaling and overall digestive wellness*^1,4,7

View Certificate of Analysis (1)

View Certificate of Analysis (2)

View Certificate of Analysis (3)

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. BPC-157 is an investigational synthetic peptide that has not been approved by the FDA for any use. All supporting research is from preclinical animal studies and may not translate to humans.

Next-Level Synbiotic Support

Introducing BPC-157 Ultra Probiotic — a formula that goes beyond traditional probiotics. Rather than simply adding bacteria, this holistic blend takes a systems-level approach to digestive health. By reinforcing multiple layers of the gut ecosystem, it supports whole-body wellness from the inside out.^1-3,6-9

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

How It Works

It starts with BPC-157, a peptide naturally present in gastric juices. Preclinical animal research has explored BPC-157 in connection with gut barrier function, mucosal comfort, and a healthy inflammatory response within normal ranges in the GI tract. All BPC-157 research is from animal and cell studies; human clinical trials have not been completed.^4-6,10

Building on this foundation, a strategic blend of prebiotics, probiotics, and postbiotics is designed to amplify butyrate — the short-chain fatty acid that fuels and protects the colon. Butyrate is the key metabolite that unifies and supports the benefits of this synbiotic system.*^1-3

Important: All cited research for BPC-157 reflects preclinical findings from animal and cell studies. Human clinical trials establishing these effects have not been completed and conclusions about efficacy in humans should not be drawn from this data alone.

Why Butyrate Matters

Butyrate is the preferred fuel for colonocytes — the cells that line and protect the gut. It helps keep the intestinal barrier functioning normally, supports a balanced microbiome, and promotes healthy digestive function.*^1-3

Many people don’t produce enough. Butyrate is generated by specific gut bacteria, yet modern diets are often low in the fibers and polyphenols those microbes need. When butyrate is lacking, colon cells turn to less efficient fuels. This shift can affect barrier function, inflammatory balance, and gut–brain signaling.*^1-3

That’s why BPC-157 Ultra Probiotic goes beyond standard probiotics. Rather than just adding bacteria and hoping they take hold, it works at the root: delivering butyrate directly while enhancing your body’s natural production. More butyrate means stronger gut function... and whole-body wellness that radiates from the inside out.*^1-3,6-9

BPC-157 Ultra Probiotic addresses this at multiple levels: delivering butyrate directly while also supporting the conditions for natural production.*^1-3,6-9

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

What Makes Ours Better?

(Peptide) BPC-157
Formulated with Body Protection Compound-157, a peptide studied in preclinical animal models in the context of gut barrier function, mucosal comfort, and healthy inflammatory balance within the GI tract. All BPC-157 research is preclinical; effects in humans have not been established.*

(Prebiotic) MicrobiomeX®
Citrus polyphenols studied for their role in supporting butyrate-producing bacteria in the microbiome.*¹

(Probiotic) Clostridium butyricum
A spore-forming strain that survives stomach acid, activates in the intestines, and supports butyrate production where it is needed.*³

(Postbiotic) ButyraGen®
A targeted tributyrin that delivers butyrate directly to the colon, supporting digestive comfort.*²

A Holistic Strategy
By targeting gut structure, microbial balance, and metabolite production, this formula supports multiple layers of the gut ecosystem for lasting digestive wellness.*^1-3,6-9

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Why Choose ProHealth?

• Science-Reviewed Formulation: Reviewed by our science team with input from wellness professionals to support key areas associated with healthy aging.*
• Triple Lab Tested: Rigorously tested by independent third-party labs to verify potency and purity.
• Full Transparency: In an industry full of misleading claims, we publish our third-party lab results—so you always know exactly what’s in every bottle.
• Manufactured in the USA: Since 1988, supplements have been produced in FDA-registered, GMP-certified facilities, supporting high quality and safety standards.^2,5
• 100-Day Risk-Free Guarantee: If you’re not completely satisfied, contact the Santa Barbara, CA office for a full refund—no hassle, no questions asked.

Chief Science Officer Quote

“With BPC-157 Ultra Probiotic, our goal was to create a formula that doesn’t just seed the gut, but supports it at multiple levels. We brought together a peptide studied in preclinical models for its role in gut barrier comfort, clinically researched pre- and probiotics to nourish the microbiome, and targeted tributyrin to deliver butyrate where it’s needed most. The result is a systems-level approach to digestive health, with butyrate at the center as the key metabolite.”

Ingredient Info

BPC-157
A synthetic 15-amino acid peptide naturally present in gastric secretions. Studied in preclinical animal models in the context of gut barrier function, mucosal comfort, and healthy inflammatory balance within the GI tract.* All research is preclinical. BPC-157 is an investigational compound that has not been approved by the FDA for any use.

MicrobiomeX®
Prebiotic citrus polyphenols clinically shown to beneficially modulate the gut microbiome and support a butyrate‑favorable SCFA profile.*¹

Clostridium butyricum
A spore-forming probiotic strain that survives gastric conditions and supports butyrate production in the intestines.*³

ButyraGen® (Tributyrin)
A postbiotic that delivers butyrate directly to the colon, supporting colonocyte fuel and digestive comfort. Clinical studies show a 26.4% improvement in digestive comfort.*²

Recommended additional disclosures
² In a randomized, double‑blind, placebo‑controlled study, post‑menopausal women taking 200 mg/day ButyraGen® for 6 weeks experienced a 26.4% greater improvement in belly pain and digestive comfort scores compared with placebo.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. BPC-157 is an investigational synthetic peptide that has not been approved by the FDA for any use. All BPC-157 research is from preclinical animal studies and may not translate to humans.

References:

1. Sost MM et al. Nutrients. 2021;13(11):3915.
2. Dosz E et al. Nutraceuticals. 2025;5(2):14.
3. Stoeva MK et al. Gut Microbes. 2021;13(1):1907272.
4. Vukojevic J et a. Neural Regen Res. 2022;17(3):482-487.
5. Cushman CJ et al. Yale J Biol Med. 2024;97(3):399-413.
6. Klicek R et al. J Physiol Pharmacol Off J Pol Physiol Soc. 2013;64(5):597-612.
7. Sikiric P et al. Pharm Basel Switz. 2023;16(5):676.
8. Vukusic D et al. J Physiol Pharmacol Off J Pol Physiol Soc. 2024;75(1).
9. Veljaca M et al. J Pharmacol Exp Ther. 1995;272(1):417-422.
10. Gwyer D et a. Cell Tissue Res. 2019;377(2):153-159.
11. Sikiric P et al. J Physiol Paris. 2001;95(1-6):283-288.